|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-controlled, non-affiliated investments | ||||||||||||||||
| Non-controlled, Non-affiliated Investments | ||||||||||||||||
| Controlled, Affiliated Investments | ||||||||||||||||
| Investment, Unaffiliated Issuer | ||||||||||||||||
| Total non-controlled, non-affiliated investments | ||||||||||||||||
| Cash and Cash Equivalents, Cost | ||||||||||||||||
| Cash equivalents (cost - $50,725 and $40,729, respectively) | ||||||||||||||||
| Cash (cost - $50,090 and $81,955, respectively) | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Distributions receivable | ||||||||||||||||
| Receivable for investments sold | ||||||||||||||||
| Due from affiliates | ||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||
| Total assets | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Credit Facility payable, at fair value (cost - $318,355 and $683,855, respectively) | ||||||||||||||||
| Notes payable, net | ||||||||||||||||
| 2023 Notes Payable | ||||||||||||||||
| 2026 Notes Payable | ||||||||||||||||
| 2029 Notes Payable | ||||||||||||||||
| 2031 Notes Payable | ||||||||||||||||
| Asset-Backed Debt, net | ||||||||||||||||
| 2031 Asset-Backed Debt | ||||||||||||||||
| 2036 Asset-Backed Debt | ||||||||||||||||
| 2036-R Asset-Backed Debt | ||||||||||||||||
| 2037 Asset-Backed Debt | ||||||||||||||||
| 2038-R Asset-Backed Debt | ||||||||||||||||
| Total asset-Backed Debt, net | ||||||||||||||||
| Payable for investments purchased | ||||||||||||||||
| Interest payable on debt | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Base management fee payable | ||||||||||||||||
| Incentive fee payable | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Deferred tax liability | ||||||||||||||||
| Due to affiliates | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Net assets | ||||||||||||||||
| Common stock, 99,217,896 and 99,217,896 shares issued and outstanding, respectively Par value $0.001 per share and 200,000,000 shares authorized | ||||||||||||||||
| Paid-in capital in excess of par value | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total net assets | ||||||||||||||||
| Total liabilities and net assets | ||||||||||||||||
| Net asset value per share | ||||||||||||||||
Loading...
